PEAK6’s Moderna MRNA Stock Holding History

PEAK6’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.04M	Buy	158,300 +151,200	+2,130%	+$7.05M	0.02%	672
2025 Q4	$209K	Hold	7,100	–	–	﹤0.01%	2377
2025 Q3	$183K	Sell	7,100 -21,800	-75%	-$608K	﹤0.01%	2495
2025 Q2	$797K	Sell	28,900 -763,000	-96%	-$20.1M	﹤0.01%	1916
2025 Q1	$22.5M	Buy	791,900 +642,400	+430%	+$22.8M	0.05%	304
2024 Q4	$6.22M	Buy	+149,500	New	+$7.15M	0.01%	785

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6's MRNA Position: Q1 2026 in Review

PEAK6 reduced its Moderna (MRNA) stake by 37% in Q1 2026, selling an estimated $1.67M and leaving 60,583 shares worth $3.08M. The position accounts for 0.01% of the portfolio, ranked #1148.

PEAK6 first reported a position in MRNA in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.67M in Q2 2025. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

PEAK6 held 60,583 shares of Moderna worth $3.08M as of Q1 2026.
PEAK6 sold 35,773 Moderna shares in Q1 2026, an estimated $1.67M.
Moderna made up 0.01% of PEAK6's portfolio in Q1 2026, its #1148 holding.
PEAK6 first reported a position in Moderna in Q4 2024 and has held it in 6 quarters since.
PEAK6's Moderna position peaked at $8.67M in Q2 2025.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.